147 related articles for article (PubMed ID: 22992234)
1. Genetic biomarkers in acute myeloid leukemia: will the promise of improving treatment outcomes be realized?
Yang J; Schiffer CA
Expert Rev Hematol; 2012 Aug; 5(4):395-407. PubMed ID: 22992234
[TBL] [Abstract][Full Text] [Related]
2. Rethinking the gold standard for recurrent DNA mutations detection in acute myeloid leukemia.
Novaretti MC
Eur J Haematol; 2016 Feb; 96(2):109-10. PubMed ID: 26110968
[No Abstract] [Full Text] [Related]
3. Perspectives for therapeutic targeting of gene mutations in acute myeloid leukaemia with normal cytogenetics.
Falini B; Sportoletti P; Brunetti L; Martelli MP
Br J Haematol; 2015 Aug; 170(3):305-22. PubMed ID: 25891481
[TBL] [Abstract][Full Text] [Related]
4. Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemia.
Alpermann T; Schnittger S; Eder C; Dicker F; Meggendorfer M; Kern W; Schmid C; Aul C; Staib P; Wendtner CM; Schmitz N; Haferlach C; Haferlach T
Haematologica; 2016 Feb; 101(2):e55-8. PubMed ID: 26471486
[No Abstract] [Full Text] [Related]
5. Complex molecular genetic abnormalities involving three or more genetic mutations are important prognostic factors for acute myeloid leukemia.
Wakita S; Yamaguchi H; Ueki T; Usuki K; Kurosawa S; Kobayashi Y; Kawata E; Tajika K; Gomi S; Koizumi M; Fujiwara Y; Yui S; Fukunaga K; Ryotokuji T; Hirakawa T; Arai K; Kitano T; Kosaka F; Tamai H; Nakayama K; Fukuda T; Inokuchi K
Leukemia; 2016 Mar; 30(3):545-54. PubMed ID: 26488113
[TBL] [Abstract][Full Text] [Related]
6. [THE CLINICAL SIGNIFICANCE OF GENETIC MUTATIONS IN ACUTE MYELOID LEUKEMIA].
Goryainova NV
Lik Sprava; 2014 Dec; (12):10-8. PubMed ID: 26638462
[TBL] [Abstract][Full Text] [Related]
7. Genomics in acute myeloid leukemia: from identification to personalization.
Martin JM; Winer ES
R I Med J (2013); 2015 Nov; 98(11):27-30. PubMed ID: 26517252
[TBL] [Abstract][Full Text] [Related]
8. Overall survival in acute myeloid leukaemia patients with and without internal tandem duplication.
Shahab S; Qadar Z; Nadeem M; Zahid D; Ansari S; Farzana T; Taj M; Borhany M; Ahmed N; Shamsi TS
Asian Pac J Cancer Prev; 2015; 16(1):393. PubMed ID: 25640387
[No Abstract] [Full Text] [Related]
9. Acute myeloid leukemia with normal cytogenetics.
Mawad R; Estey EH
Curr Oncol Rep; 2012 Oct; 14(5):359-68. PubMed ID: 22806102
[TBL] [Abstract][Full Text] [Related]
10. Mutant DNMT3A in acute myeloid leukemia: guilty of inducing genetic instability?
Zebisch A; Hoefler G; Quehenberger F; Wölfler A; Sill H
Leukemia; 2013 Aug; 27(8):1777-8. PubMed ID: 23417030
[No Abstract] [Full Text] [Related]
11. Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications.
Marcucci G; Haferlach T; Döhner H
J Clin Oncol; 2011 Feb; 29(5):475-86. PubMed ID: 21220609
[TBL] [Abstract][Full Text] [Related]
12. Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients.
Tien FM; Hou HA; Tsai CH; Tang JL; Chen CY; Kuo YY; Li CC; Lin CT; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Tseng MH; Liu MC; Liu CW; Lin LI; Chou WC; Tien HF
Eur J Haematol; 2018 Jul; 101(1):86-94. PubMed ID: 29624746
[TBL] [Abstract][Full Text] [Related]
13. Molecular prognostic factors in cytogenetically normal acute myeloid leukemia.
Walker A; Marcucci G
Expert Rev Hematol; 2012 Oct; 5(5):547-58. PubMed ID: 23146058
[TBL] [Abstract][Full Text] [Related]
14. Role of genotype-based approach in the clinical management of adult acute myeloid leukemia with normal cytogenetics.
Cagnetta A; Adamia S; Acharya C; Patrone F; Miglino M; Nencioni A; Gobbi M; Cea M
Leuk Res; 2014 Jun; 38(6):649-59. PubMed ID: 24726781
[TBL] [Abstract][Full Text] [Related]
15. Mutational landscape of AML with normal cytogenetics: biological and clinical implications.
Martelli MP; Sportoletti P; Tiacci E; Martelli MF; Falini B
Blood Rev; 2013 Jan; 27(1):13-22. PubMed ID: 23261068
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetics of acute myeloid leukemia: clinical implications and opportunities for integrating genomics into clinical practice.
Abdel-Wahab O
Hematology; 2012 Apr; 17 Suppl 1():S39-42. PubMed ID: 22507776
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathogenesis of AML: translating insights to the clinic.
Levine RL
Best Pract Res Clin Haematol; 2013 Sep; 26(3):245-8. PubMed ID: 24309525
[TBL] [Abstract][Full Text] [Related]
18. From DNA Sequencing to Clinical Trials: Finding New Targeted Drugs for Acute Myeloid Leukemia.
Yilmaz M; Daver N
Drugs; 2019 Jul; 79(11):1177-1186. PubMed ID: 31222627
[TBL] [Abstract][Full Text] [Related]
19. DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies.
Im AP; Sehgal AR; Carroll MP; Smith BD; Tefferi A; Johnson DE; Boyiadzis M
Leukemia; 2014 Sep; 28(9):1774-83. PubMed ID: 24699305
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors of acute myeloid leukemia].
Inokuchi K
Nihon Rinsho; 2012 Apr; 70 Suppl 2():389-93. PubMed ID: 23133988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
